Parallel Advisors, LLC Seres Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 20, 2024	SELL	$4.67 - $6.55 $107 - $150	-23 Reduced 58.97%	16 $0
Q2 2023 Aug 04, 2023	SELL	$4.67 - $6.55 $107 - $150	-23 Reduced 58.97%	16 $0
Q1 2023 May 20, 2024	BUY	$4.95 - $6.09 $193 - $237	39 New	39 $0
Q1 2023 Apr 25, 2023	BUY	$4.95 - $6.09 $193 - $237	39 New	39 $0
Q1 2022 Apr 28, 2022	SELL	$6.3 - $8.84 $0 - $0	0 Closed	0 $0

Q4 2021 Jan 20, 2022	BUY	$6.02 - $11.43 $0 - $0	0 New	0 $0

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.